Incretin‐based drugs and risk of lung cancer among individuals with type 2 diabetes-Reference-Cited by-同舟云学术

Incretin‐based drugs and risk of lung cancer among individuals with type 2 diabetes

Author:

Rouette J.¹²,Yin H.¹,Yu O. H. Y.¹³,Bouganim N.⁴⁵,Platt R. W.¹²,Azoulay L.¹²⁴^ORCID

Affiliation:

1. Centre for Clinical Epidemiology Lady Davis Institute Jewish General Hospital Montreal QC Canada

2. Department of Epidemiology, Biostatistics, and Occupational Health McGill University Montreal QC Canada

3. Division of Endocrinology Jewish General Hospital Montreal QC Canada

4. Gerald Bronfman Department of Oncology McGill University Montreal QC Canada

5. Department of Oncology McGill University Health Centre Montreal QC Canada

Funder

Canadian HIV Trials Network, Canadian Institutes of Health Research

Fonds de Recherche du Québec - Santé

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

Reference30 articles.

5. Epidermal growth factor receptor (EGFR) in lung cancer: an overview and update;Bethune G;J Thorac Dis,2010

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献